Pelvic floor rehabilitation (PFR) is an important and recommended strategy for the treatment of many uro-gynaecological disorders including overactive bladder (OAB), urinary incontinence (UI), chronic pelvic pain (CPP) and pelvic organ prolapse (POP). The recognised pioneer of PFR is the American gynaecologist Arnold Kegel who, over 60 years ago, proposed pelvic floor muscles exercises to prevent and/or treat female UI. Kegel's techniques were also successfully used by other authors, but until the first International Consultation on Incontinence (ICI) there was no scientific consensus regarding the efficacy of PFR (Monaco, 1998). PFR consists of biofeedback (BFB), functional electrical stimulation (FES), pelvic floor muscle training (PFMT), endovaginal or vaginal cones (VC), and behavioural approaches. BFB allows the subject to modify the unconscious physiological events, while FES is aimed to inhibit OAB, and improve pelvic "awareness", in association with pelvic floor muscles activity. PFMT plays an extremely important role in the conservative treatment of OAB, UI and CPP, but in the near future it should also be proposed as an actual secondary and primary prevention of pelvic floor dysfunction. Many Authors use the rehabilitation techniques according to heterogeneous protocols: the best results are obtained when protocols requiring intensive and/or supervised PFMT are followed. Keywords: Neurogenic bladder; Urodynamic Urodynamics is a key tool for assessment of urinary disorders in many neurological disorders. Urodynamics assess the function and dysfunction of the lower urinary tract, trying to reproduce the patient's complaints and provide a pathophysiological explanation to guide therapeutics. But for each of the different etiologies, specific questions are addressed regarding the value of urodynamic for diagnostic, prognostic, evaluation of treatment efficacy, and follow-up.
Urodynamic in SCI is of particular importance regarding the risk for upper urinary tract impairment and morbidity and mortality related to urinary disorders. Each arm of treatment in this population requires specific evaluation and urodynamic goals. Urodynamic in MS is a subject of debate in the literature and scientific society guidelines. The place of urodynamic in this pathology will be discussed. Urodynamic in Parkinson disease help the clinician to make the diagnostic of Parkinson disease or multiple system atrophy. Because of the epidemiology, age and gender, the question of association with prolapse and benign prostate hypertrophy is a frequent. Results.-From 2001 to 2013, 102 patients have been implanted. Mean ± SD at implantation was 48.4 ± 16.5 years. The mean follow-up was 2.7 ± 2.3 years. The mean urethral closure-pressure was 33.2 ± 18.7 cm H 2 0. The mean maximum detrusor storage pressure was 28.5 ± 18.1 cm H 2 0. Among patients, 3.9% were dry, 37.3% were improved 50% or greater of whom 11.8% of patients with 90% or greater improvement, 39.2% were improved less than 50% of whom 5.9% with treatment failure. Complications were found in 74 1877-0657/$ -see front matter e90
Diseases of the genito-urinary system / Annals of Physical and Rehabilitation Medicine 57S (2014) . 95% of patients underwent an augmentation cystoplasty. Fifty-one patients underwent a concomitant procedure for continence. Two post-operative severe complications (grade III-IV) were reported. Seven patients had a stoma or tube stenosis: six were treated by dilation, one received surgery. Eight patients had bladder stone managed with endoscopy. Seven patients had remnant stress urine leakage through the urethra, which was treated surgically: four received periurethral balloons (ACT/Pro-ACT ® ), 2 a fascial sling, and 1 a tension-free vaginal tape. Creatinine clearance had improved post-operatively in all patients. At last (IQR 29, 5) . Prior continence surgery was reported by 7 patients. AUS was implanted in peribulbar(n = 5) or periprostatic position(n = 5). Median follow-up was 15.5years (IQR 9,2-20,7). The explantation of the device due to erosion was reported in 3 patients. The 10-, 15-, 20-year explantation-free survival rate was 87.5%. The 10-, 15-year revision-free survival rate was 28% and 0% respectively. At last follow-up, 70% patients were continent. Discussion.-AUS provided good functional outcomes in neurological patients but the revision rates were important in the very long run.
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Long-term functional outcomes after management of neurogenic bladder dysfunction with ileal conduit in an adult spina bifida population: A monocentric experience among a multidisciplinary team
